The FDA did require label updates for GLP-1 drugs like Ozempic and Zepbound to include warnings about vision problems, particularly diabetic retinopathy worsening in people with diabetes. This doesn't mean you should automatically stop taking the medication - it means you need to be informed and proactive about monitoring your eyes. The main concern is that rapid weight loss and blood sugar changes can affect the blood vessels in your retinas, especially if you already have diabetes or early signs of eye disease. That's why your doctor should know about any existing vision issues before you start.
What you're actually watching for: blurry vision, floaters, flashing lights, or shadows in your peripheral vision. If you notice anything off with your sight, report it to your eye doctor right away rather than waiting for your next scheduled appointment. People with diabetes should be getting regular eye exams anyway, but if you're on these medications, make sure your eye doctor knows that specifically. It's not about panicking - it's about having baseline knowledge of what's normal for you and catching changes early.
The bigger picture is that these drugs work fast, and your body's adjusting to significant changes in a short timeframe. That adjustment period is when complications are most likely to show up. Your prescribing doctor should have discussed this with you, but if they didn't, ask about it directly. You're not choosing between your eyesight and the medication - you're managing both together with proper monitoring.